Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy – (Eye 29, 1199 (September 2015))
Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy Eye 29, 1199 (September 2015). doi:10.1038/eye.2015.114 Authors: K Ghasemi Falavarjani, M Modarres, A Hadavandkhani & A Karimi Moghaddam
Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren’s syndrome – (Eye 29, 1204 (September 2015))
Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren’s syndrome Eye 29, 1204 (September 2015). doi:10.1038/eye.2015.125 Authors: N Yokoi, Y Sonomura, H Kato, A Komuro & S Kinoshita
Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment – (Eye 29, 1213 (September 2015))
Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment Eye 29, 1213 (September 2015). doi:10.1038/eye.2015.126 Authors: M S Dikopf, K H Patel, V J Setlur & J I Lim
Effect of laser suture lysis on filtration openings: a prospective three-dimensional anterior segment optical coherence tomography study – (Eye 29, 1220 (September 2015))
Effect of laser suture lysis on filtration openings: a prospective three-dimensional anterior segment optical coherence tomography study Eye 29, 1220 (September 2015). doi:10.1038/eye.2015.129 Authors: H-k Cho, S Kojima, T Inoue, A Fukushima, C Kee & H Tanihara
Diverse clinical phenotypes associated with a nonsense mutation in FAM161A – (Eye 29, 1226 (September 2015))
Diverse clinical phenotypes associated with a nonsense mutation in FAM161A Eye 29, 1226 (September 2015). doi:10.1038/eye.2015.93 Authors: A M Rose, P Sergouniotis, G Alfano, N Muspratt-Tucker, S Barton, A T Moore, G Black, S S Bhattacharya & A R Webster